| 今开：11.72 | 昨收：11.94 |
| 最高：12.12 | 最低：11.38 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：6.04590376E8 |
chuminhua03-27 12:10
3/26，Stoke Therapeutics $Stoke Therapeutics(STOK)$ 公布了其实验药物 STK-001 在 Dravet 综合征患者中进行的两项 I/IIa 期研究的积极数据，周二该公司股价飙升 92%。 该公司现在计划与监管机构讨论这个反义寡核苷酸注册试验的设计。
去年，Stoke公布的试验结果表明，该公司寻找有效的 STK-...查看全文
Stoke Therapeutics(STOK)02-14 22:25
$Stoke Therapeutics(STOK)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001610 Act: 34 Size: 64 KB 网页链接查看全文
Stoke Therapeutics(STOK)02-09 22:55
$Stoke Therapeutics(STOK)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000315066-24-001457 Act: 34 Size: 8 KB 网页链接查看全文
Stoke Therapeutics(STOK)03-20 08:35
$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008683 Size: 9 KB 网页链接查看全文
Stoke Therapeutics(STOK)03-29 04:45
$Stoke Therapeutics(STOK)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-002743 Act: 33 Size: 4 KB 网页链接查看全文
Stoke Therapeutics(STOK)04-02 04:15
$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009532 Size: 6 KB 网页链接查看全文
Stoke Therapeutics(STOK)03-06 05:25
$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-006623 Size: 9 KB 网页链接查看全文
Stoke Therapeutics(STOK)04-12 04:15
$Stoke Therapeutics(STOK)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-24-093195 Act: 33 Size: 82 KB 网页链接查看全文
Stoke Therapeutics(STOK)04-30 04:15
$Stoke Therapeutics(STOK)$ 8-K Current report, item 5.02 Accession Number: 0001193125-24-122215 Act: 34 Size: 152 KB 网页链接查看全文
Stoke Therapeutics(STOK)03-26 04:15
$Stoke Therapeutics(STOK)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-24-076478 Act: 34 Size: 3 MB 网页链接查看全文
美股指南2019-06-17 20:34
摘要: 医药股 Stoke Therapeutics，Inc 于06月19 美股上市,价格为: 14.00-16.00美元; 股票代码: $Stoke Therapeutics(STOK)$ ; IPO承销商: 摩根大通、考恩、瑞士信贷、Canaccord Genuity。 $京东(JD)$
公司简介
STOK正在开创一种通过精确调节蛋白质来治疗严重遗传疾病的新方法。目前STOK...查看全文
$Stoke Therapeutics(STOK)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-053535 Act: 34 Size: 5 MB 网页链接
$Stoke Therapeutics(STOK)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-053195 Act: 34 Size: 342 KB 网页链接
$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-012173 Size: 9 KB 网页链接
$Stoke Therapeutics(STOK)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-003280 Act: 33 Size: 7 KB 网页链接
$Stoke Therapeutics(STOK)$ 8-K Current report, item 5.02 Accession Number: 0001193125-24-122215 Act: 34 Size: 152 KB 网页链接
$Stoke Therapeutics(STOK)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-106979 Act: 34 Size: 762 KB 网页链接
$Stoke Therapeutics(STOK)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-106991 Act: 34 Size: 444 KB 网页链接
$Stoke Therapeutics(STOK)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-107021 Act: 34 Size: 11 MB 网页链接
$Stoke Therapeutics(STOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-008547 Size: 10 KB 网页链接
$Stoke Therapeutics(STOK)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001123292-24-000113 Act: 34 Size: 177 KB 网页链接